<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02767323</url>
  </required_header>
  <id_info>
    <org_study_id>Pro00065334</org_study_id>
    <secondary_id>1R01AG050618-01</secondary_id>
    <nct_id>NCT02767323</nct_id>
  </id_info>
  <brief_title>Using TMS to Increase Executive Function in Older Adults</brief_title>
  <acronym>WMTMS</acronym>
  <official_title>Using fMRI-guided TMS to Increase Central Executive Function in Older Adults</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Duke University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute on Aging (NIA)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Duke University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Cognitive decline and dementia have become important public health issues in our time as&#xD;
      medical science has increased lifespan and our society becomes progressively older. A great&#xD;
      deal of the cognitive decline due to aging can be explained by decline in working memory&#xD;
      (WM), a mental function central to cognition in which aging deficits appear almost&#xD;
      universally. Attempts to use WM training to increase WM ability in older adults has had some&#xD;
      success, but the transfer of performance enhancements caused by this training to other&#xD;
      cognitive skills is controversial. Another intervention that shows much promise is&#xD;
      noninvasive stimulation of cerebral cortex using transcranial magnetic stimulation (TMS),&#xD;
      which has been shown to increase performance in many cognitive tasks.&#xD;
&#xD;
      Here, the investigator proposes to use fMRI-guided rTMS to enhance working memory&#xD;
      performance. This will be achieved through three Aims. In the first, registered on this&#xD;
      record, the investigator will stimulate both old and young healthy adults while they perform&#xD;
      the WM task that will engage the frontoparietal network. To define the optimal rTMS target,&#xD;
      rTMS will be applied over the dorsolateral prefrontal cortex (DLPFC: Aim 1a); or over the&#xD;
      parietal cortex (PC: Aim 1b). These regions are involved not only in the maintenance of items&#xD;
      in WM, but also in their manipulation, therefore applying rTMS over these areas should create&#xD;
      WM performance enhancements that will be long-lasting. In Aim 1c, a direct within-subject&#xD;
      comparison of these 2 targeted sites is performed.&#xD;
&#xD;
      In the second and third Aims, older adults will receive active or sham rTMS over the optimal&#xD;
      target (defined in Arm 1) during two weeks of daily sessions while they perform the WM tasks.&#xD;
      In the second Aim, the investigator hopes to demonstrate that the cumulative effect of&#xD;
      multiple TMS sessions, in tandem with the synergistic effects of simultaneous TMS + WM&#xD;
      training, create WM performance enhancements greater than those found with WM training alone,&#xD;
      whose effects are long-lasting, continuing a month following the course of TMS sessions. In&#xD;
      the third, the investigator will investigate whether the WM enhancements generated by the two&#xD;
      weeks of TMS sessions will generalize to other cognitive tasks. The success of these 3 Aims&#xD;
      will provide proof in principle for long-lasting, transferable effects of TMS in remediating&#xD;
      WM and more general cognitive deficits due to aging, and point to a possible non-invasive&#xD;
      brain stimulation therapy for cognitive decline in healthy aging and in dementia. This record&#xD;
      is a reflection of Aim1, Aim 2 and 3 will be registered separately.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">August 15, 2016</start_date>
  <completion_date type="Actual">March 16, 2020</completion_date>
  <primary_completion_date type="Actual">March 16, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Factorial Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Acute Effect of a rTMS Session on the Performance for a Working Memory Task, as Measured by Accuracy (in Percentage)</measure>
    <time_frame>During the rTMS session, on average 2 hours per visit.</time_frame>
    <description>Accuracy (in percentage) will be assessed to evaluate the acute effect of rTMS. The accuracy provided below are the ones obtained in the hardest condition of the working memory task.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Acute Effect of a rTMS Session on the Performance for a Working Memory Task, as Measured by Reaction Time of Correct Response (in ms)</measure>
    <time_frame>During the rTMS session, on average 2 hours per visit</time_frame>
    <description>Reaction Time of correct response (in ms) will be assessed to evaluate the acute effect of rTMS. The reaction times provided below are the ones obtained in the hardest condition of the working memory task.</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">184</enrollment>
  <condition>Aging</condition>
  <arm_group>
    <arm_group_label>Active or Sham rTMS over the DLPFC (Aim1a)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>excitatory rTMS applied over the DLPFC (fMRI-guided). Active and Sham rTMS will be tested in a within subject design</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Active or Sham rTMS over the Parietal cortex (Aim1b)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>excitatory rTMS applied over the parietal cortex (fMRI-guided). Active and Sham rTMS will be tested in a within subject design</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Active or Sham rTMS over the DLPFC and the Parietal cortex (Aim1c)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>excitatory rTMS applied over the DLPFC and the parietal cortex (fMRI-guided). Active and Sham rTMS will be tested in a within subject design</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>rTMS</intervention_name>
    <description>excitatory 5Hz rTMS will be used</description>
    <arm_group_label>Active or Sham rTMS over the DLPFC (Aim1a)</arm_group_label>
    <arm_group_label>Active or Sham rTMS over the DLPFC and the Parietal cortex (Aim1c)</arm_group_label>
    <arm_group_label>Active or Sham rTMS over the Parietal cortex (Aim1b)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Sham rTMS</intervention_name>
    <description>an electrical sham coil reproducing the same clicking sound and tactile sensation than the active rTMS will be used</description>
    <arm_group_label>Active or Sham rTMS over the DLPFC (Aim1a)</arm_group_label>
    <arm_group_label>Active or Sham rTMS over the DLPFC and the Parietal cortex (Aim1c)</arm_group_label>
    <arm_group_label>Active or Sham rTMS over the Parietal cortex (Aim1b)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age Restrictions: Young Group (from 18 to 35 years old), Elderly Group (from 60 to 80&#xD;
             years old).&#xD;
&#xD;
          -  Use of effective method of birth control for women of childbearing capacity.&#xD;
&#xD;
          -  Willing to provide informed consent.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Current or recent (within the past 6 months) history of substance abuse or dependence.&#xD;
&#xD;
          -  Current serious medical illness.&#xD;
&#xD;
          -  History of seizure, epilepsy, stroke, brain surgery, head injury, cranial metal&#xD;
             implants, known structural brain lesion, devices that may be affected by rTMS or MRI&#xD;
             (pacemaker, medication pump, cochlear implant, implanted brain stimulator)&#xD;
&#xD;
          -  Inability or unwilling to give informed consent.&#xD;
&#xD;
          -  Diagnosed any Axis I DSM-IV disorder (MINI, DSM-IV).&#xD;
&#xD;
          -  For subjects age &gt; 59 years, a total scaled score &lt; 8 on the Dementia Rating Scale-2.&#xD;
&#xD;
          -  Clinically defined neurological disorder.&#xD;
&#xD;
          -  Increased risk of seizure for any reason, including prior diagnosis of increased&#xD;
             intracranial pressure, or currently taking medication that lowers the seizure&#xD;
             threshold.&#xD;
&#xD;
          -  Claustrophobia (MRI scanner).&#xD;
&#xD;
          -  Pregnancy.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Lawrence Appelbaum</last_name>
    <role>Principal Investigator</role>
    <affiliation>Duke University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Duke University Medical Center</name>
      <address>
        <city>Durham</city>
        <state>North Carolina</state>
        <zip>27705</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>May 5, 2016</study_first_submitted>
  <study_first_submitted_qc>May 6, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 10, 2016</study_first_posted>
  <results_first_submitted>February 4, 2021</results_first_submitted>
  <results_first_submitted_qc>March 9, 2021</results_first_submitted_qc>
  <results_first_posted type="Actual">April 5, 2021</results_first_posted>
  <last_update_submitted>March 9, 2021</last_update_submitted>
  <last_update_submitted_qc>March 9, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 5, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>January 19, 2021</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/23/NCT02767323/Prot_000.pdf</document_url>
    </provided_document>
    <provided_document>
      <document_type>Statistical Analysis Plan</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>January 19, 2021</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/23/NCT02767323/SAP_001.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Active or Sham rTMS Over the DLPFC (Aim1a)</title>
          <description>excitatory rTMS applied over the DLPFC (fMRI-guided)&#xD;
rTMS: excitatory 5Hz rTMS will be used Active and Sham rTMS will be tested in a within subject design</description>
        </group>
        <group group_id="P2">
          <title>Active or Sham rTMS Over the Parietal Cortex (Aim1b)</title>
          <description>excitatory rTMS applied over the parietal cortex (fMRI-guided)&#xD;
rTMS: excitatory 5Hz rTMS will be used Active and Sham rTMS will be tested in a within subject design</description>
        </group>
        <group group_id="P3">
          <title>Active or Sham rTMS Over the DLPFC and the Parietal Cortex (Aim 1c)</title>
          <description>excitatory rTMS applied over the the DLPFC and the parietal cortex (fMRI-guided)&#xD;
rTMS: excitatory 5Hz rTMS will be used. Active and Sham rTMS will be tested in a within subject design</description>
        </group>
        <group group_id="P4">
          <title>Active/Sham rTMS Over DLPFC (Aim1a), Then Active/Sham rTMS Over DLPFC and Parietal Cortex (Aim1c)</title>
          <description>excitatory rTMS applied over the DLPFC (fMRI-guided) and the Parietal cortex&#xD;
rTMS: excitatory 5Hz rTMS will be used Active and Sham rTMS will be tested in a within subject design</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="83"/>
                <participants group_id="P2" count="42"/>
                <participants group_id="P3" count="58"/>
                <participants group_id="P4" count="1"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="49"/>
                <participants group_id="P2" count="17"/>
                <participants group_id="P3" count="28"/>
                <participants group_id="P4" count="1"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="34"/>
                <participants group_id="P2" count="25"/>
                <participants group_id="P3" count="30"/>
                <participants group_id="P4" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="17"/>
                <participants group_id="P2" count="5"/>
                <participants group_id="P3" count="13"/>
                <participants group_id="P4" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Contraindication, moving during the scan, low behavior, or Covid-19</title>
              <participants_list>
                <participants group_id="P1" count="17"/>
                <participants group_id="P2" count="20"/>
                <participants group_id="P3" count="17"/>
                <participants group_id="P4" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Active or Sham rTMS Over the DLPFC (Aim1a)</title>
          <description>excitatory rTMS applied over the DLPFC (fMRI-guided)&#xD;
rTMS: excitatory 5Hz. Active and Sham rTMS will be tested in a within subject design</description>
        </group>
        <group group_id="B2">
          <title>Active or Sham rTMS Over the Parietal Cortex (Aim1b)</title>
          <description>excitatory rTMS applied over the parietal cortex (fMRI-guided)&#xD;
rTMS: excitatory 5Hz. Active and Sham rTMS will be tested in a within subject design</description>
        </group>
        <group group_id="B3">
          <title>Active or Sham rTMS Over the DLPFC and the Parietal Cortex (Aim 1c)</title>
          <description>excitatory rTMS applied over the the DLPFC and the parietal cortex (fMRI-guided)&#xD;
rTMS: excitatory 5Hz. Active and Sham rTMS will be tested in a within subject design</description>
        </group>
        <group group_id="B4">
          <title>Active or Sham rTMS Over the DLPFC (Aim1a), Then Active or Sham rTMS Over the DLPFC (Aim1c)</title>
          <description>excitatory rTMS applied over the the DLPFC and the parietal cortex (fMRI-guided)&#xD;
rTMS: excitatory 5Hz. Active and Sham rTMS will be tested in a within subject design</description>
        </group>
        <group group_id="B5">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="83"/>
            <count group_id="B2" value="42"/>
            <count group_id="B3" value="58"/>
            <count group_id="B4" value="1"/>
            <count group_id="B5" value="184"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="57"/>
                    <measurement group_id="B2" value="18"/>
                    <measurement group_id="B3" value="58"/>
                    <measurement group_id="B4" value="1"/>
                    <measurement group_id="B5" value="134"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="26"/>
                    <measurement group_id="B2" value="24"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="50"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="40.85" spread="23.09"/>
                    <measurement group_id="B2" value="67.26" spread="6.23"/>
                    <measurement group_id="B3" value="23.65" spread="4.14"/>
                    <measurement group_id="B4" value="28" spread="1.4"/>
                    <measurement group_id="B5" value="41.31" spread="22.47"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="52"/>
                    <measurement group_id="B2" value="16"/>
                    <measurement group_id="B3" value="34"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="102"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="31"/>
                    <measurement group_id="B2" value="26"/>
                    <measurement group_id="B3" value="24"/>
                    <measurement group_id="B4" value="1"/>
                    <measurement group_id="B5" value="82"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="14"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="13"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="27"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="6"/>
                    <measurement group_id="B2" value="5"/>
                    <measurement group_id="B3" value="11"/>
                    <measurement group_id="B4" value="1"/>
                    <measurement group_id="B5" value="23"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="62"/>
                    <measurement group_id="B2" value="37"/>
                    <measurement group_id="B3" value="33"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="132"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="1"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="2"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="83"/>
                    <measurement group_id="B2" value="42"/>
                    <measurement group_id="B3" value="58"/>
                    <measurement group_id="B4" value="1"/>
                    <measurement group_id="B5" value="184"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Acute Effect of a rTMS Session on the Performance for a Working Memory Task, as Measured by Accuracy (in Percentage)</title>
        <description>Accuracy (in percentage) will be assessed to evaluate the acute effect of rTMS. The accuracy provided below are the ones obtained in the hardest condition of the working memory task.</description>
        <time_frame>During the rTMS session, on average 2 hours per visit.</time_frame>
        <population>Subjects who completed the study. Data not collected on five subjects.</population>
        <group_list>
          <group group_id="O1">
            <title>Active or Sham rTMS Over the DLPFC (Aim1a)</title>
            <description>excitatory rTMS applied over the DLPFC (fMRI-guided)&#xD;
rTMS: excitatory 5Hz rTMS will be used. Active and Sham rTMS will be tested in a within subject design</description>
          </group>
          <group group_id="O2">
            <title>Active or Sham rTMS Over the Parietal Cortex (Aim1b)</title>
            <description>excitatory rTMS applied over the parietal cortex (fMRI-guided)&#xD;
rTMS: excitatory 5Hz rTMS will be used Active and Sham rTMS will be tested in a within subject design</description>
          </group>
          <group group_id="O3">
            <title>Active or Sham rTMS Over the DLPFC and the Parietal Cortex (Aim 1c)</title>
            <description>excitatory rTMS applied over the the DLPFC and the parietal cortex (fMRI-guided)&#xD;
rTMS: excitatory 5Hz rTMS will be used. Active and Sham rTMS will be tested in a within subject design</description>
          </group>
        </group_list>
        <measure>
          <title>Acute Effect of a rTMS Session on the Performance for a Working Memory Task, as Measured by Accuracy (in Percentage)</title>
          <description>Accuracy (in percentage) will be assessed to evaluate the acute effect of rTMS. The accuracy provided below are the ones obtained in the hardest condition of the working memory task.</description>
          <population>Subjects who completed the study. Data not collected on five subjects.</population>
          <units>percentage of accuracy</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="46"/>
                <count group_id="O2" value="15"/>
                <count group_id="O3" value="29"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Active rTMS</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="50.43" spread="7.37"/>
                    <measurement group_id="O2" value="55.42" spread="5.50"/>
                    <measurement group_id="O3" value="83.93" spread="8.09"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Sham rTMS</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="46.49" spread="7.35"/>
                    <measurement group_id="O2" value="57.76" spread="5.70"/>
                    <measurement group_id="O3" value="83.27" spread="10.88"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Acute Effect of a rTMS Session on the Performance for a Working Memory Task, as Measured by Reaction Time of Correct Response (in ms)</title>
        <description>Reaction Time of correct response (in ms) will be assessed to evaluate the acute effect of rTMS. The reaction times provided below are the ones obtained in the hardest condition of the working memory task.</description>
        <time_frame>During the rTMS session, on average 2 hours per visit</time_frame>
        <population>Subjects who completed the study. Data not collected on five subjects.</population>
        <group_list>
          <group group_id="O1">
            <title>Active or Sham rTMS Over the DLPFC (Aim1a)</title>
            <description>excitatory rTMS applied over the DLPFC (fMRI-guided)&#xD;
rTMS: excitatory 5Hz rTMS will be used. Active and Sham rTMS will be tested in a within subject design</description>
          </group>
          <group group_id="O2">
            <title>Active or Sham rTMS Over the Parietal Cortex (Aim1b)</title>
            <description>excitatory rTMS applied over the parietal cortex (fMRI-guided)&#xD;
rTMS: excitatory 5Hz rTMS will be used Active and Sham rTMS will be tested in a within subject design</description>
          </group>
          <group group_id="O3">
            <title>Active or Sham rTMS Over the DLPFC and the Parietal Cortex (Aim 1c)</title>
            <description>excitatory rTMS applied over the the DLPFC and the parietal cortex (fMRI-guided)&#xD;
rTMS: excitatory 5Hz rTMS will be used. Active and Sham rTMS will be tested in a within subject design</description>
          </group>
        </group_list>
        <measure>
          <title>Acute Effect of a rTMS Session on the Performance for a Working Memory Task, as Measured by Reaction Time of Correct Response (in ms)</title>
          <description>Reaction Time of correct response (in ms) will be assessed to evaluate the acute effect of rTMS. The reaction times provided below are the ones obtained in the hardest condition of the working memory task.</description>
          <population>Subjects who completed the study. Data not collected on five subjects.</population>
          <units>ms</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="46"/>
                <count group_id="O2" value="15"/>
                <count group_id="O3" value="29"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Active rTMS</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2368" spread="335"/>
                    <measurement group_id="O2" value="2214" spread="231"/>
                    <measurement group_id="O3" value="1911" spread="356"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Sham rTMS</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2388" spread="345"/>
                    <measurement group_id="O2" value="2224" spread="180"/>
                    <measurement group_id="O3" value="1924" spread="332"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>During the rTMS session and a few minutes after, up to 10 minutes</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Active rTMS Over the DLPFC (Aim1a)</title>
          <description>excitatory rTMS applied over the DLPFC (fMRI-guided)&#xD;
rTMS: excitatory 5Hz Active and Sham rTMS will be tested in a within subject design</description>
        </group>
        <group group_id="E2">
          <title>Sham rTMS Over the DLPFC (Aim1a)</title>
          <description>excitatory rTMS applied over the DLPFC (fMRI-guided)&#xD;
rTMS: excitatory 5Hz Active and Sham rTMS will be tested in a within subject design</description>
        </group>
        <group group_id="E3">
          <title>Active rTMS Over the Parietal Cortex (Aim 1b)</title>
          <description>excitatory rTMS applied over the parietal cortex (fMRI-guided)&#xD;
rTMS: excitatory 5Hz rTMS will be used Active and Sham rTMS will be tested in a within subject design</description>
        </group>
        <group group_id="E4">
          <title>Sham rTMS Over the Parietal Cortex (Aim 1b)</title>
          <description>excitatory rTMS applied over the parietal cortex (fMRI-guided)&#xD;
rTMS: excitatory 5Hz rTMS will be used Active and Sham rTMS will be tested in a within subject design</description>
        </group>
        <group group_id="E5">
          <title>Active rTMS Over the DLPFC and the Parietal Cortex (Aim 1c)</title>
          <description>excitatory rTMS applied over the DLPFC and the parietal cortex (fMRI-guided)&#xD;
rTMS: excitatory 5Hz rTMS will be used Active and Sham rTMS will be tested in a within subject design</description>
        </group>
        <group group_id="E6">
          <title>Sham rTMS Over the DLPFC and the Parietal Cortex (Aim 1c)</title>
          <description>excitatory rTMS applied over the DLPFC and the parietal cortex (fMRI-guided)&#xD;
rTMS: excitatory 5Hz rTMS will be used Active and Sham rTMS will be tested in a within subject design</description>
        </group>
        <group group_id="E7">
          <title>Active rTMS Over the DLPFC (Aim1a) Then Active rTMS Over the DLPFC and Parietal Cortex(Aim1c)</title>
          <description>excitatory rTMS applied over the DLPFC and the parietal cortex (fMRI-guided)&#xD;
rTMS: excitatory 5Hz rTMS will be used Active and Sham rTMS will be tested in a within subject design</description>
        </group>
        <group group_id="E8">
          <title>Sham rTMS Over the DLPFC (Aim1a) Then Sham rTMS Over the DLPFC and Parietal Cortex(Aim1c)</title>
          <description>excitatory rTMS applied over the DLPFC and the parietal cortex (fMRI-guided)&#xD;
rTMS: excitatory 5Hz rTMS will be used Active and Sham rTMS will be tested in a within subject design</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="83"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="83"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="1"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="83"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="83"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="1"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="83"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="83"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="1"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr. Lysianne Beynel</name_or_title>
      <organization>Duke University</organization>
      <phone>9193386273</phone>
      <email>lysianne.beynel@gmail.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

